Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukino Kimura

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 3, 2005
[Cross-presentation pathway]Yukino Kimura, Kayo Inaba
European Journal of Immunology|March 15, 2011
C-type lectin SIGNR1 enhances cellular oxidative burst response against C. albicans in cooperation with Dectin-1Kazuhiko Takahara, Sumika Tokieda, Koji Nagaoka, et al.
The Journal of Experimental Medicine|October 23, 2002
Immune tolerance after delivery of dying cells to dendritic cells in situKang Liu, Tomonori Iyoda, Marzena Saternus, et al.
Springerplus|December 25, 2015
Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART)Yukino Kimura, Yui Harada, Noriko Yasuda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49QYoshiki Omatsu, Tomonori Iyoda, Yukino Kimura, et al.
International Immunology|December 2, 2010
Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulationTomonori Iyoda, Maki Ushida, Yukino Kimura, et al.
International Immunology|April 21, 2004
Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectinsKazuhiko Takahara, Yusuke Yashima, Yoshiki Omatsu, et al.
Pancreas|July 28, 2011
Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinomaYukino Kimura, Jun Tsukada, Takeshi Tomoda, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 3, 2005
[Cross-presentation pathway]Yukino Kimura, Kayo Inaba
European Journal of Immunology|March 15, 2011
C-type lectin SIGNR1 enhances cellular oxidative burst response against C. albicans in cooperation with Dectin-1Kazuhiko Takahara, Sumika Tokieda, Koji Nagaoka, et al.
The Journal of Experimental Medicine|October 23, 2002
Immune tolerance after delivery of dying cells to dendritic cells in situKang Liu, Tomonori Iyoda, Marzena Saternus, et al.
Springerplus|December 25, 2015
Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART)Yukino Kimura, Yui Harada, Noriko Yasuda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49QYoshiki Omatsu, Tomonori Iyoda, Yukino Kimura, et al.
International Immunology|December 2, 2010
Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulationTomonori Iyoda, Maki Ushida, Yukino Kimura, et al.
International Immunology|April 21, 2004
Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectinsKazuhiko Takahara, Yusuke Yashima, Yoshiki Omatsu, et al.
Pancreas|July 28, 2011
Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinomaYukino Kimura, Jun Tsukada, Takeshi Tomoda, et al.
Pageof 1